Yin K - Search Results

1

Potential health-promoting effects of astaxanthin: a high-value carotenoid mostly from microalgae.

Yuan JP, Peng J, Yin K, Wang JH. Yuan JP, et al. Among authors: yin k. Mol Nutr Food Res. 2011 Jan;55(1):150-65. doi: 10.1002/mnfr.201000414. Epub 2010 Nov 18. Mol Nutr Food Res. 2011. PMID: 21207519 Review.

2

Genomic and immune characteristics of HER2-mutated non-small-cell lung cancer and response to immune checkpoint inhibitor-based therapy.

Tu HY, Yin K, Zhao X, Ke EE, Wu SP, Li YS, Zheng MM, Liu SM, Xu CR, Sun YL, Lin JX, Bai XY, Zhang YC, Zhou Q, Yang JJ, Zhong WZ, Wang BC, Zhang XC, Zhu D, Yang L, Ou Q, Wu YL. Tu HY, et al. Among authors: yin k. Mol Oncol. 2023 Aug;17(8):1581-1594. doi: 10.1002/1878-0261.13439. Epub 2023 Apr 29. Mol Oncol. 2023. PMID: 37078460 Free PMC article.

3

Spatial downregulation of CD74 signatures may drive invasive component development in part-solid lung adenocarcinoma.

Zhang JT, Zhang J, Wang SR, Yan LX, Qin J, Yin K, Chu XP, Wang MM, Hong HZ, Lv ZY, Dong S, Jiang BY, Zhang XC, Liu X, Zhou Q, Wu YL, Zhong WZ. Zhang JT, et al. Among authors: yin k. iScience. 2023 Aug 21;26(10):107699. doi: 10.1016/j.isci.2023.107699. eCollection 2023 Oct 20. iScience. 2023. PMID: 37810252 Free PMC article.

4

Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastases.

Zheng MM, Li YS, Tu HY, Sun H, Yin K, Jiang BY, Yang JJ, Zhang XC, Zhou Q, Xu CR, Wang Z, Chen HJ, Zhou DX, Wu YL. Zheng MM, et al. Among authors: yin k. BMC Med. 2022 May 30;20(1):197. doi: 10.1186/s12916-022-02387-0. BMC Med. 2022. PMID: 35644609 Free PMC article.

5

A molecular graded prognostic assessment (molGPA) model specific for estimating survival in lung cancer patients with leptomeningeal metastases.

Yin K, Li YS, Zheng MM, Jiang BY, Li WF, Yang JJ, Tu HY, Zhou Q, Zhong WZ, Yang XN, Chen HJ, Yan HH, Li LL, Wu YL, Zhang XC. Yin K, et al. Lung Cancer. 2019 May;131:134-138. doi: 10.1016/j.lungcan.2019.03.015. Epub 2019 Mar 18. Lung Cancer. 2019. PMID: 31027690

6

Low frequency of mutation of epidermal growth factor receptor (EGFR) and arrangement of anaplastic lymphoma kinase (ALK) in primary pulmonary lymphoepithelioma-like carcinoma.

Yin K, Feng HB, Li LL, Chen Y, Xie Z, Lv ZY, Guo WB, Lu DX, Yang XN, Yan WQ, Wu YL, Zhang XC. Yin K, et al. Thorac Cancer. 2020 Feb;11(2):346-352. doi: 10.1111/1759-7714.13271. Epub 2019 Dec 3. Thorac Cancer. 2020. PMID: 31794146 Free PMC article.

7

An integrated biomarker of PD-L1 expression and intraepithelial CD8⁺ T cell infiltration was associated with the prognosis of lung cancer patients after intracranial resection of brain metastases.

Li LL, Zhou DX, Lu M, Zhou D, Lin XF, Chen Y, Yin K, Feng HB, Guo WB, Xie Z, Yan WQ, Lv ZY, Lu DX, Zhang SL, Zhang XC. Li LL, et al. Among authors: yin k. Thorac Cancer. 2022 Jul;13(13):1948-1960. doi: 10.1111/1759-7714.14473. Epub 2022 May 20. Thorac Cancer. 2022. PMID: 35596539 Free PMC article.

8

Multiomics analysis reveals a distinct response mechanism in multiple primary lung adenocarcinoma after neoadjuvant immunotherapy.

Zhang C, Yin K, Liu SY, Yan LX, Su J, Wu YL, Zhang XC, Zhong WZ, Yang XN. Zhang C, et al. Among authors: yin k. J Immunother Cancer. 2021 Apr;9(4):e002312. doi: 10.1136/jitc-2020-002312. J Immunother Cancer. 2021. PMID: 33820821 Free PMC article.

9

Prediction of unfavourable response to checkpoint blockade in lung cancer patients through an integrated tumour-immune expression score.

Liu SM, Sun H, Zhou JY, Zhang JT, Yin K, Chen ZH, Su J, Zhang XC, Yang JJ, Zhou Q, Tu HY, Wu YL. Liu SM, et al. Among authors: yin k. Transl Oncol. 2022 Jan;15(1):101254. doi: 10.1016/j.tranon.2021.101254. Epub 2021 Oct 26. Transl Oncol. 2022. PMID: 34715621 Free PMC article.

10

PD-1/PD-L1 combined with LAG3 is associated with clinical activity of immune checkpoint inhibitors in metastatic primary pulmonary lymphoepithelioma-like carcinoma.

Zhong YM, Yin K, Chen Y, Xie Z, Lv ZY, Yang JJ, Yang XN, Zhou Q, Wang BC, Zhong WZ, Gao LL, Zhou WB, Chen J, Tu HY, Liao RQ, Zhang DK, Zhang SL, Lu DX, Zheng HB, Zhang HH, Wu YL, Zhang XC. Zhong YM, et al. Among authors: yin k. Front Immunol. 2022 Oct 3;13:951817. doi: 10.3389/fimmu.2022.951817. eCollection 2022. Front Immunol. 2022. PMID: 36263036 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,669 results

Search Page